Clinical Trial Update: Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FOLFOX6 plus cetuximab versus FOLFIRI plus cetuximab in patients with metastatic colorectal cancer, assessing safety and efficacy; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• FOLFOX6

Snippet

Sponsor: Central European Cooperative Oncology Group | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED